January 11, 2026 (InterContinental San Francisco) — We’re pleased to announce that Diyong Xu, Partner at OrbiMed, will speak at the ACCESS ASIA BD Forum @ JPM 2026.
ACCESS ASIA, hosted by YAFO, builds on the success of ACCESS CHINA, expanding Asia’s leading cross-border biotech platform to connect innovators with global pharma, investors, and strategic partners. Taking place on January 11, 2026, at the InterContinental San Francisco, the forum provides a global stage for Asian biotech companies to showcase their innovation, foster partnerships, and explore new business development opportunities. View more information at: https://biotochina.org/
About the speaker
Diyong Xu is a Partner at OrbiMed in New York, where he focuses on venture capital investments in biotech, medtech, and diagnostics companies. Prior to joining OrbiMed, Diyong worked as an investment banker in the healthcare group at Lazard, concentrating on M&A, financings, and strategic advisory projects.
Diyong holds an M.S. in Management Science and Engineering from Stanford University and an M.S. in Molecular and Cellular Biology from Dartmouth College. He earned his B.S. in Biology from Zhejiang University in China.
About ACCESS ASIA BD Forum @ JPM 2026
ACCESS ASIA BD Forum @ JPM is scheduled to be held on January 11, 2026, at the InterContinental San Francisco, alongside the J.P. Morgan Healthcare Conference Week.
This full-day forum will feature keynote speeches, panel discussions, corporate presentations, company showcases, and 1-on-1 partnering meetings connecting Asia’s leading biotech innovators with global pharma, investors, and strategic partners.
Conference Name: ACCESS ASIA BD Forum @ JPM 2026
Date & Venue: January 11, 2026 | InterContinental San Francisco
View more information at: https://biotochina.org/
MORE INFORMATION
Contact Us
Register as an attendee for ACCESS ASIA BD Forum @ JPM:
For more information, please contact:
Wendi Xiang | Wxiang@yafocapital.com
BioToChina.org 